Literature DB >> 722120

Chemokinetic and chemotactic factors in psoriasis scale extracts.

M V Dahl, W E Lindroos, R D Nelson.   

Abstract

Soluble solutions of psoriasis scale were prepared by extracting scales in 6 m urea and removing urea by dialysis. Extracts were tested for chemokinetic and chemotactic activity for human polymorphonuclear leukocytes and mononuclear cells in vitro using the migration under agarose assay. Five of 6 extracts demonstrated significant chemotactic activity for polymorphonuclear leukocytes, and 4 or 6 were also chemotactic for mononuclear cells. All extracts augmented random migration of polymorphonuclear leukoyctes (chemokinesis). Checkerboard epxeriments showed extracts were truly chemotactic as well as chemokinetic. The kinetics of polymorphonuclear leukocyte and mononuclear cell chemotaxis toward psoriasis scale extracts were similar to kinetics of chemotaxis toward a bacteria-derived chemotactic factor and zymosan-activated serum. Since zymosan-activated serum and purified C5a were not chemokinetic, psoriasis scale extract was more like a bacteria-culture supernate than these complement factors in augmenting random migration of polymorphonuclear leukocytes. Substances in psoriasis scale may be capable of influencing the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 722120     DOI: 10.1111/1523-1747.ep12558281

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  Decreased extracellular release of granule enzymes from in vitro-stimulated polymorphonuclear leukocytes in guttate psoriasis.

Authors:  W Glinski; M Tigalonowa; S Jablonska; E Janczura
Journal:  Inflammation       Date:  1986-06       Impact factor: 4.092

2.  Effect of topical applications of heavy suspensions of killed Malassezia ovalis on rabbit skin.

Authors:  E W Rosenberg; P Belew; G Bale
Journal:  Mycopathologia       Date:  1980-11-28       Impact factor: 2.574

Review 3.  Psoriasis and its treatment.

Authors:  R H Champion
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-31

4.  Circadian rhythm of the in vivo migration of neutrophils in psoriatic patients.

Authors:  P D Pigatto; A Radaelli; G Tadini; M M Polenghi; L Brambilla; G Altomare; F Carandente
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

5.  Migration-stimulating effect of psoriatic scales on polymorphonuclear leukocytes.

Authors:  S Lidén; O Bäck; A Pettersson
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

6.  Psoriatic leukotactic factor. Further physicochemical characterization and effect on the epidermal cells.

Authors:  H Tagami; Y Kitano; S Suehisa; T Oku; M Yamada
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 7.  The role of complement-derived mediators in inflammatory skin diseases.

Authors:  H Tagami
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

8.  Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leucocytes.

Authors:  Y Miyachi; Y Niwa
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

9.  Neutrophil chemotaxis in psoriasis before and after PUVA therapy.

Authors:  B Guillot; J J Guilhou; J P Vendrel; J Meynadier
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

Review 10.  Complement Activation in Inflammatory Skin Diseases.

Authors:  Jenny Giang; Marc A J Seelen; Martijn B A van Doorn; Robert Rissmann; Errol P Prens; Jeffrey Damman
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.